2001
Wood W.-J., Vargas X., Schwartz G., Dongier M. (2001). À propos de la guérison naturelle, de l'effet dit placebo et des études psychopharmacologiques dans le traitement de l'alcoolisme . Dans Brochu S., Guyon. L. , Landry M. & Brochu S. (Éds.) , Impact du traitement en alcoolisme et toxicomanie : études québécoises (pp. 173-187). Presses de l'Université Laval.
Xu Y. C., Johnson K. W., Phebus L. A., Cohen M., Nelson D. L., Schenck K., Walker C., Fritz J. E., Kaldor S. W., LeTourneau M. E., Murff R. E., Zgombick J. M., Calligaro D. O., Audia J. E., Schaus J. M. (2001). N-[3-(2-Dimethylaminoethyl)-2-methyl-1H- indol-5-yl]-4-fluorobenzamide: a potent, selective, and orally active 5-HT(1F) receptor agonist potentially useful for migraine therapy, J Med Chem, 44(24), 4031-4.
Yamamoto K., Bloom D., La S., Turecki G., Joober R., Benkelfat C., Lalonde P., Labelle A., Rouleau G. A. (2001). Polymorphism in the cell division cycle 45 like gene and schizophrenia, Am J Med Genet, 105(2), 214-5.
Zhou L., Rowley D. L., Mi Q. S., Sefcovic N., Matthes H. W., Kieffer B., Donovan D. M. (2001). Murine inter-strain polymorphisms alter gene targeting frequencies at the mu opioid receptor locus in embryonic stem cells, Mamm Genome, 12(10), 772-8. En savoir plus.
2000
Bigoni R., Rizzi A., Rizzi D., Becker J. A., Kieffer B., Simonin F., Regoli D., Calo G. (2000). In vitro pharmacological profile of peptide III-BTD: a novel ligand for nociceptin/orphanin FQ and opioid receptors, Life Sci, 68(2), 233-9. En savoir plus.
Filliol D., Ghozland S., Chluba J., Martin M., Matthes H. W., Simonin F., Befort K., Gaveriaux-Ruff C., Dierich A., LeMeur M., Valverde O., Maldonado R., Kieffer B. (2000). Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses, Nat Genet, 25(2), 195-200. En savoir plus.
Fleck M. P., Louzada S., Xavier M., Chachamovich E., Vieira G., Santos L., Pinzon V. (2000). [Application of the Portuguese version of the abbreviated instrument of quality life WHOQOL-bref], Rev Saude Publica, 34(2), 178-83. En savoir plus.
Kieffer B. (2000). Opioid receptors: from genes to mice, J Pain, 1(3 Suppl), 45-50. En savoir plus.
Monory K., Bourin M. C., Spetea M., Tomboly C., Toth G., Matthes H. W., Kieffer B., Hanoune J., Borsodi A. (2000). Specific activation of the mu opioid receptor (MOR) by endomorphin 1 and endomorphin 2, Eur J Neurosci, 12(2), 577-84. En savoir plus.
Roberts A. J., McDonald J. S., Heyser C. J., Kieffer B., Matthes H. W., Koob G. F., Gold L. H. (2000). mu-Opioid receptor knockout mice do not self-administer alcohol, J Pharmacol Exp Ther, 293(3), 1002-8. En savoir plus.
1999
Fleck M. P., Louzada S., Xavier M., Chachamovich E., Vieira G., Santos L., Pinzon V. (1999). [Application of the Portuguese version of the instrument for the assessment of quality of life of the World Health Organization (WHOQOL-100)], Rev Saude Publica, 33(2), 198-205. En savoir plus.
